• 2016 October 01

Company Description

Biotechnology, pathogen detection

LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a public biotechnology company developing an open-access, fully automated pathogen detection platform featuring unprecedented speed and sensitivity. LexaGene’s technology aims to transform the way organizations prevent and diagnose disease in multi-billion dollar markets such as vet diagnostics, food safety, water quality testing, and other markets.​